financetom
Business
financetom
/
Business
/
Coherent beats Q4 revenue estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Coherent beats Q4 revenue estimates
Aug 13, 2025 1:46 PM

Overview

* Coherent Q4 revenue of $1.53 bln beats analyst expectations, per LSEG data

* Non-GAAP EPS of $1.00 for Q4 exceeds analyst estimates, per LSEG data

* Co announces sale of Aerospace and Defense business to focus on growth areas

Outlook

* Coherent expects Q1 2026 revenue between $1.46 bln and $1.60 bln

* Company anticipates Q1 2026 non-GAAP gross margin of 37.5% to 39.5%

* Coherent forecasts Q1 2026 EPS between $0.93 and $1.13

* Company projects Q1 2026 operating expenses of $290 mln to $310 mln

Result Drivers

* REVENUE GROWTH - Coherent achieved a record FY25 revenue of $5.81 bln, a 23% increase year-over-year, driven by strong performance in AI datacenters, according to CEO Jim Anderson

* GROSS MARGIN EXPANSION - Co's non-GAAP gross margin expanded by 358 basis points to 37.9% in FY25, attributed to revenue growth and margin expansion, per CFO Sherri Luther

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q4 Beat $1.53 $1.51

Revenue bln bln (18

Analysts

)

Q4 Beat $1 $0.91

Adjusted (18

EPS Analysts

)

Q4 Beat $192 mln $145.90

Adjusted mln (12

Net Analysts

Income )

Q4 Beat $275 mln $272.80

Adjusted mln (15

Operatin Analysts

g Income )

Q4 18.0%

Adjusted

Operatin

g Margin

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 18 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the electronic equipment & parts peer group is "buy"

* Wall Street's median 12-month price target for Coherent Corp ( COHR ) is $104.00, about 12.1% below its August 12 closing price of $116.56

* The stock recently traded at 26 times the next 12-month earnings vs. a P/E of 15 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: HSBC Considers Combining Commercial, Investment Businesses
Market Chatter: HSBC Considers Combining Commercial, Investment Businesses
Sep 9, 2024
08:40 AM EDT, 09/09/2024 (MT Newswires) -- HSBC Holdings ( HSBC ) is mulling a combination of its commercial and investment bank divisions as part of an effort to eliminate overlapping roles across the company and cut costs, Bloomberg reported Monday, citing people familiar with the matter. The combined division would become the bank's biggest revenue creator, adding about $40...
HSBC weighs commercial, investment bank merger to shed costs, Bloomberg reports
HSBC weighs commercial, investment bank merger to shed costs, Bloomberg reports
Sep 9, 2024
(Reuters) - HSBC ( HSBC ) is mulling the combination of its Commercial and Investment banking divisions to eliminate overlapping roles at the lender and cut costs, Bloomberg News reported on Monday, citing people familiar with the matter. The combined division would become the bank's largest revenue generator, contributing about $40 billion to the lender's revenue annually, the report added....
Solaris Submits Environmental Impact Assessment for Warintza Project in Ecuador
Solaris Submits Environmental Impact Assessment for Warintza Project in Ecuador
Sep 9, 2024
08:44 AM EDT, 09/09/2024 (MT Newswires) -- Solaris Resources ( SLSR ) on Monday said it submitted an Environmental Impact Assessment (EIA) for the Warintza project to regulators in Ecuador. The company, which has already spent US$170 million on the copper and gold mining project, said it submitted the over 3,000-page study to the country's Ministry of Environment, Water and...
Moderna Says Quebec Facility Receives Drug Establishment License From Health Canada
Moderna Says Quebec Facility Receives Drug Establishment License From Health Canada
Sep 9, 2024
08:27 AM EDT, 09/09/2024 (MT Newswires) -- Moderna ( MRNA ) said Monday it has received Health Canada's Drug Establishment License for its production site in Laval, Quebec. With the license, the Laval site will move ahead with the final qualification process to manufacture mRNA vaccines against respiratory viruses, including Covid-19, starting next year, the company said. Price: 73.25, Change:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved